Principal author of PRIDE study responds to news story in The BMJ claiming that the study was based on “flawed” analysisBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g2935 (Published 29 April 2014) Cite this as: BMJ 2014;348:g2935
- Jonathan S Nguyen-Van-Tam, clinical professor of health protection, and senior author, PRIDE Consortium1
- 1University of Nottingham, Clinical Sciences Building, City Hospital, Nottingham NG5 1PB, UK
On 19 March 2014, researchers from the PRIDE (Post-pandemic Review of anti-Influenza Drug Effectiveness) Consortium published the first outputs from a project investigating the effectiveness of neuraminidase inhibitors against outcomes of public health importance during the 2009 flu pandemic in the Lancet Respiratory Medicine.1 2 The headline results suggested that neuraminidase inhibitors were associated with statistically significant reductions in mortality: overall adjusted odds ratio 0.81 (95% CI 0.70 to 0.93; P=0.0024) versus no treatment and 0.50 …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial